跳至主要内容
临床试验/NCT03469765
NCT03469765已完成不适用

(TIMP-2)x(IGFPB7) as Early Renal Biomarker for the Prediction of Acute Kidney Injury in Aortic Surgery - an Observational Study (TIGER)

Jörg Schefold1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2018年6月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100
试验地点
1
主要终点
Statistically significant difference in mean total (TIMP-2)x(IGFBP7) values of patients with/ without AKI (as defined along Kidney Disease Initiative for Improvement of global outcomes (KDIGO) definitions: stages 1-3) at the first postoperative day.

研究概览

简要总结

New biomarkers that predict the development of renal dysfunction in patients with aortic surgery are urgently needed. The investigators investigate whether urinary (TIMP-2)x(IGFBP7) predicts postoperative Acute Kidney Injury and/or need for Renal Replacement Therapy (RRT) in patients after aortic surgery (including EVAR).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients in need of emergency or elective abdominal aortic surgery (infra- or suprarenal clamping or EVAR) are eligible for study inclusion.

排除标准

  • Patients unable to give informed consent
  • Age < 18
  • Patients not speaking German or French.

结局指标

主要结局

Statistically significant difference in mean total (TIMP-2)x(IGFBP7) values of patients with/ without AKI (as defined along Kidney Disease Initiative for Improvement of global outcomes (KDIGO) definitions: stages 1-3) at the first postoperative day.

时间窗: 24 hours following ICU admission

次要结局

未报告次要终点

研究者

发起方
Jörg Schefold
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jörg Schefold

Sponsor-investigator

Insel Gruppe AG, University Hospital Bern

研究点 (1)

Loading locations...

相似试验